Bookmark

Add to MyYahoo RSS

Scios News

News on Scios (Ticker: JNJ) continually updated from thousands of sources around the net.

Thursday Apr 17 | JD Supra

Dallas Woman Awarded $1.2 Million, Mesh Called Defectively Designed

For the first time, a Texas jury has decided the pelvic mesh made by healthcare giant Johnson & Johnson was defectively designed .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Wed Apr 16, 2014

The Miami Herald

Smartphone apps to help patients take their meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Barron's

Target Price Increases Abound For J&J, But Stock Slips

Johnson & Johnson was giving up some of Tuesday's gains , although analysts were largely upbeat about the company's better-than-expected first-quarter earnings report, as evidenced by a flurry of target price increases.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Canadian Business Magazine

Forgetting to take your medicine? Smartphone apps help patients remember and track doses

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Motley Fool

Johnson & Johnson's Earnings Report Impresses

Devices and Consumer continue to log disappointing results, but the higher-margin Pharma business is more than making up the difference.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Tue Apr 15, 2014

BayStreet.ca

Twitter Buys Gnip to Monetize Data; Johnson & Johnson Beats...

Shares of Twitter closed up 11.38% on Tuesday with about 24.2 million shares traded.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Drug Researcher

TransCelerate recognizes training programs from Icon, Synteract

Industry group TransCelerate Biopharma has certified that training programs from CROs Icon and SynteractHCR meet minimum criteria for ICH's good clinical practice training.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Fox News

Wall Street Caps Turbulent Day With Solid Gains

After a volatile trading session, U.S. equity markets posted solid gains on the back of strong earnings from Coca-Cola and Johnson & Johnson.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

SchaeffersResearch.com

Midday Market Stats: Dow Jones Industrial Average Stumbles on Mixed Economic News

The Dow Jones Industrial Average was earlier trying to extend Monday's positive momentum, and helping toward this goal were Dow components The Coca-Cola Company and Johnson & Johnson , which remain in the black on well-received earnings reports.

Comment?

Related Topix: The Dow Company, Beverages, CocaCola, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Globe and Mail

Johnson & Johnson tops forecasts, helped by new medicines

In this Jan. 24, 2011 photo, Johnson & Johnson Band-Aid products are displayed, in Montpelier, Vt.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Apr 14, 2014

TheStreet.com

Investing Ahead of Earnings: Johnson & Johnson and Coca Cola

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Sun Apr 13, 2014

The Daily Record

Campaigners renew calls for end to mesh implant operations after US court says device is defective

AMERICAN victim wins A 750,000 compensation from drugs giant Johnson & Johnson in a case that could have a big impact on the civil actions for damages launched by 400 Scottish women against mesh makers and NHS Scotland.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Fri Apr 11, 2014

The Motley Fool

Here's What's Behind Puma's Crash

Alan Auerbach, the former CEO of Cougar Biotechnology -- the company that developed Johnson & Johnson 's widely successful Zytiga prostate cancer drug -- hopes he has another blockbuster potential drug on his hands at Puma Biotechnology Xeloda head to head against GlaxoSmithKline 's Tykerb and Xeloda.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Thu Apr 10, 2014

Boston.com

Law firm Mintz Levin expands intellectual property practice

William C. Geary III, Lisa Adams, and Christina Sperry have joined as members of Mintz Levin's Boston office, the firm said in a Thursday press release .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Huffington Post

Nigel Barker: Learning From Strong Women

This post is part of the Global Moms Relay . Every time you share this post, Johnson & Johnson will donate $1 to help improve the health and well-being of moms and kids worldwide through MAMA , Shot@Life , and Girl Up .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Tue Apr 08, 2014

Law.com

Janssen Settles 76 Topamax Cases in Philadelphia

Johnson & Johnson subsidiary Janssen Pharmaceuticals has settled 76 cases in which plaintiffs alleged that the anti-seizure drug Topamax, taken during pregnancy, caused birth defects, according to a Philadelphia court order.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Apr 07, 2014

NBC Philadelphia

$1.2M to Woman Hurt by J&J Mesh Implant

A Dallas jury has ordered Johnson & Johnson to pay Linda Batiste, a 64-year-old woman injured by one of the company's pelvic mesh implants, $1.2 million in compensatory damages.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Fri Apr 04, 2014

Business Wire

Transvaginal Mesh Patient Awarded $1.2 Million in Ethicon Mesh Lawsuit, Announces Baron and Budd

The mesh patient, Linda Batiste, was awarded $1.2 million for suffering serious health issues from her transvaginal mesh implant.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Third Point Urges Sotheby's Stockholders to Support Its Slate of Independent and Highly Qualified Nominees: Vote the White Proxy Card Today! )--Third Point Urges Sotheby's Stockholders to Support Its Slate of Independent and Highly Qualified Nominees: Vote the White Proxy Card Today! )--FUND A db x-trackers MSCI World Financials Index UCITS ETF ... (more)

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Jersey Journal

Jury says Johnson & Johnson must pay $1.2M over defective vaginal-mesh implant

Johnson & Johnson was ordered by a Texas jury to pay $1.2 million to a woman who alleged one of the company's lines of vaginal-mesh implants to treat incontinence was defectively designed, in the first verdict against the company over those devices.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Micrus, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••